EcoDrugPlus

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP003412
Gene Symbol: AGA03010
5 External references
56 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP004462
Gene Symbol: AGA03010
5 External references
88 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP010252
Gene Symbol: AGA03010
4 External references
118 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002754
Gene Symbol: AGA03010
4 External references
95 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP004422
Gene Symbol: AGA03010
5 External references
120 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002122
Gene Symbol: AGA03010
4 External references
111 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP009431
Gene Symbol: AGA03010
4 External references
84 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002468
Gene Symbol: AGA03010
5 External references
114 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002437
Gene Symbol: AGA03010
5 External references
115 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP005131
Gene Symbol: AGA03010
5 External references
92 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP006612
Gene Symbol: AGA03010
5 External references
78 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP000654
Gene Symbol: AGA03010
5 External references
72 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).